Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line

British Journal of Pharmacology

Volumn 135, Issue 2, 2002, Pages 462-468

  Robert, C ^a   Pruneau, D ^a   Paquet, J L ^a  

^a Laboratoires Fournier SA   (France)

Author keywords

Binding; Bradykinin; cDNA; CHO K1; Guinea pig; Mutation; Phosphoinositides; Sequence analysis

Indexed keywords

2 [[4 [4 (AMINOIMINOMETHYL)BENZOYL] 1 PIPERAZINYL]CARBONYL] 1 [2,4 DICHLORO 3 [(2,4 DIMETHYL 8 QUINOLINYL)OXYMETHYL]PHENYLSULFONYL]PYRROLIDINE; 3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; ASPARAGINE; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; INOSITOL PHOSPHATE; KALLIDIN; LEUCINE; LF 160335 C; PHOSPHATIDYLINOSITIDE; PROLINE; PYRROLIDINE DERIVATIVE; TRITIUM; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG EFFECT; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; GUINEA PIG; ILEUM; LUNG; NONHUMAN; NUCLEOTIDE SEQUENCE; PKA; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; SEQUENCE ANALYSIS;

EID: 0036174788     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704494     Document Type: Article

References (41)

1. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657
2. 2 receptor antagonist, FR173657
3. 1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways
4. 2 receptor
5. Stable expression of human kinin B1 receptor in 293 cells: Pharmacological and functional characterization
6. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands
7. Bioregulalion of kinins: Kallikreins, kininogens, and kininases
8. RNA editing
9. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction
10. 9-bradykinin
11. 3 receptor
12. 2 receptor
13. 2 receptor antagonist, Hoe 140, in isolated blood vessels from different species
14. Human pigmentation phenotype: A point mutation generates nonfunctional MSH receptor
15. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor
16. 2 bradykinin receptors
17. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor
18. Hoe 140 a new potent and long acting bradykinin-antagonist: In vitro studies
19. Allotopic, noncompetitive, and irreversible antagonism
20. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
21. The apparatus for nuclear splicing
22. 1 receptor induction and inflammation
23. 2 receptor induced by mutations in transmembrane helices III and VI
24. 2 bradykinin receptor
25. 1 bradykinin receptor
26. 2 receptor: Inter-species variability and dissociation between binding and functional responses
27. 2 receptor second intracellular loop and proximal C terminus is critical for signal transduction, internalization, and resensitization
28. 2 receptor
29. Kinin formation: Mechanisms and role in inflammatory disorders
30. 2 receptor in the guinea-pig
31. 2 receptor
32. 2 receptor antagonist; LF 16-0335C, on guinea-pig and rat kinin receptors
33. Bradykinin stimulation of phosphoinositide hydrolysis in guinea-pig ileum longitudinal muscle
34. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein
35. Pharmacology of bradykinin and related kinins
36. 2 receptor characterization
37. 2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin)
38. Bradykinin antagonists: Development and applications
39. 2 noncompetitive antagonist, on guinea pig tracheal bradykinin receptors
40. Site-directed mutagenesis of alpha 2A-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists
41. Chimeric muscarinic cholinergic: Beta-adrenergic receptors that activate Gs in response to muscarinic agonists